BIIB stock news
This page provides real-time market news, earnings updates, and company announcements related to Biogen Inc. (BIIB).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-04-17 13:08 EST
Cardano News Today: Cardano's Vital $0.67 Level May Spark a Surge Toward $1.70
Bitget-RWA2025-10-31 20:34:11
The 5 Most Interesting Analyst Questions From Biogen's Q4 Earnings Call
Finviz2026-02-13 09:18:09
Wedbush Lifts PT on Biogen Inc. (BIIB) to $187 From $178 - Here's Why
Finviz2026-02-13 15:01:03
Strong Analyst Confidence in C4 Therapeutics (CCCC)'s Cemsidomide Drives 270% Upside Potential
Finviz2026-02-20 17:03:42
BioMarin Pharmaceutical Earnings: What To Look For From BMRN
Finviz2026-02-22 03:12:03
United Therapeutics (UTHR) Q4 Earnings Report Preview: What To Look For
Finviz2026-02-24 03:27:47
Novavax (NVAX) Q4 Earnings Report Preview: What To Look For
Finviz2026-02-25 11:12:43
Novavax (NVAX) Q4 Earnings Report Preview: What To Look For
Finviz2026-02-25 11:12:43
Denali Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights
Finviz2026-02-26 21:03:46
Immunology, Neuroscience Step Up as Key Growth Engines for J&J
Finviz2026-03-03 15:12:48
The New England Journal of Medicine Publishes First Data to Demonstrate the Potential for Disease Modification in Dravet Syndrome
Finviz2026-03-04 22:09:07
What Makes Biogen (BIIB) an Attractive Long-Term Holding?
Finviz2026-03-05 13:39:04
LRMR Stock on the Move: What Sparked the 55% Jump in the Past Month?
Finviz2026-03-06 16:31:04
C4 Therapeutics (CCCC) Well Positioned With Cemsidomide Trial Data
Finviz2026-03-10 00:13:04
CAMP4 Appoints Michael MacLean to its Board of Directors
Finviz2026-03-24 11:03:56
Biogen Announces Second Positive Phase 2 Litifilimab Trial in Cutaneous Lupus Erythematosus at 2026 American Academy of Dermatology Annual Meeting, Showing a Significant Reduction in Skin Disease Activity
Finviz2026-03-28 19:03:41
Apellis shares surge over 142% in pre-market trading, Biogen to acquire pharmaceutical company Apellis for $5.6 billion
华尔街见闻2026-03-31 11:00:58
Pre-market Highlights for US Stocks: All Three Major Index Futures Rise Over 1%! Nvidia Invests $2 Billion in Marvell Technology
格隆汇2026-03-31 12:50:14
Biogen shares suffered a heavy setback, with intraday losses widening to 7.7%—the lowest level since January this year—after the company announced a $5.6 billion acquisition of Apellis Pharmaceuticals Inc.
老虎证券2026-03-31 13:43:28
BioMarin Pharmaceutical Earnings: What To Look For From BMRN
Finviz2026-02-22 03:12:03
United Therapeutics (UTHR) Q4 Earnings Report Preview: What To Look For
Finviz2026-02-24 03:27:47
Novavax (NVAX) Q4 Earnings Report Preview: What To Look For
Finviz2026-02-25 11:12:43
Novavax (NVAX) Q4 Earnings Report Preview: What To Look For
Finviz2026-02-25 11:12:43
Denali Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights
Finviz2026-02-26 21:03:46
Immunology, Neuroscience Step Up as Key Growth Engines for J&J
Finviz2026-03-03 15:12:48
The New England Journal of Medicine Publishes First Data to Demonstrate the Potential for Disease Modification in Dravet Syndrome
Finviz2026-03-04 22:09:07
What Makes Biogen (BIIB) an Attractive Long-Term Holding?
Finviz2026-03-05 13:39:04
LRMR Stock on the Move: What Sparked the 55% Jump in the Past Month?
Finviz2026-03-06 16:31:04
C4 Therapeutics (CCCC) Well Positioned With Cemsidomide Trial Data
Finviz2026-03-10 00:13:04
CAMP4 Appoints Michael MacLean to its Board of Directors
Finviz2026-03-24 11:03:56
Biogen Announces Second Positive Phase 2 Litifilimab Trial in Cutaneous Lupus Erythematosus at 2026 American Academy of Dermatology Annual Meeting, Showing a Significant Reduction in Skin Disease Activity
Finviz2026-03-28 19:03:41
Apellis shares surge over 142% in pre-market trading, Biogen to acquire pharmaceutical company Apellis for $5.6 billion
华尔街见闻2026-03-31 11:00:58
Pre-market Highlights for US Stocks: All Three Major Index Futures Rise Over 1%! Nvidia Invests $2 Billion in Marvell Technology
格隆汇2026-03-31 12:50:14
Biogen shares suffered a heavy setback, with intraday losses widening to 7.7%—the lowest level since January this year—after the company announced a $5.6 billion acquisition of Apellis Pharmaceuticals Inc.
老虎证券2026-03-31 13:43:28
BIIB stock chart
BIIB stock detailsBIIB stock price change
On the last trading day, BIIB stock closed at 180.54 USD, with a price change of 0.88% for the day.
Trade stock perpsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more